ISNCT

Category: Year 2020

Accelerators Article Physics Year 2020

Increasing the Electric Strength of a Vacuum-Insulated Tandem Accelerator

Post author By ISNCT
Post date March 29, 2023

Instruments and Experimental Techniques,, 2020

Tags and S. Taskaev., I. Sorokin, Ia. Kolesnikov, Instruments and Experimental Techniques

Article Boron Compounds Boron Determination Chemistry In-vitro Studies Year 2020

Ruthenium carboranyl complexes with 2,2’-bipyridine derivatives for potential bimodal therapy application

Post author By ISNCT
Post date September 27, 2022

RSC Advances, 2020

Tags C. Viñas and A. Valente, F. Marques, M.H. Garcia, M.P. Robaloc, R.G. Teixeira, RSC Advances, S. Geninatti Crich, Xavier Fontrodona

Article Boron Compounds Chemistry In-vitro Studies In-vivo Studies Radiobiology Year 2020

Sunitinib containing carborane pharmacophore with ability to inhibit tyrosine kinases receptors, FLT3, KIT, and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity

Post author By ISNCT
Post date September 27, 2022

Cancers, 2020

Tags B. Dávila, C. Alamón, C. Sánche, C. Viñas, Cancers, E. Trias, F. Teixidor, L. Barbeito, M. Couto and H. Cerecetto, M. Gabay, M. Gavish, M. Kovacs, M.F. García, N. Zeineh

Article Boron Compounds Boron Determination Chemistry In-vitro Studies Radiobiology Year 2020

Closo-carboranyl- and Metallacarboranyl[1,2,3]-triazolyl-decorated Lapatinib-scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy

Post author By ISNCT
Post date September 27, 2022

Cells, 2020

Tags C. Alamón, C. Viñas and H. Cerecetto, Cells, E. Pozzi, E. Trias, F. Teixidor, M. Couto, M. Kovacs, M.A. Dagrosa, M.F. García, P. Curotto, S. Nievas, S. Thorp

Article Boron Compounds Chemistry In-vitro Studies Radiobiology Year 2020

Bimodal Therapeutic Agent against Glioblastoma, one the most Lethal Cancer

Post author By ISNCT
Post date September 27, 2022

Chemistry European Journal, 2020

Tags C. Alamón, C. Viñas and H. Cerecetto, Chemistry European Journal, F. Teixidor, M. Couto, M. Perona, M.A. Dagrosa, P. Cabral, S. Nievas

Article Boron Compounds Chemistry Year 2020

Too Persistent to Give Up: Aromaticity in Boron Clusters Survives Radical Structural Changes

Post author By ISNCT
Post date September 27, 2022

Journal of the American Chemical Society, 2020

Tags C. Viñas, F. Teixidor, I. Bennour, J. Poater, Journal of the American Chemical Society, M. Solà, S. Escayola

Article Biology Boron Determination Boron imaging In-vitro Studies In-vivo Studies Year 2020

Glioma stem-like cells can be targeted in boron neutron capture therapy with boronophenylalanine

Post author By ISNCT
Post date June 29, 2022

Cancers, 2020

Tags Cancers, Eishu Hirata, Masaki Hikida, Minoru Suzuki, Mitsutoshi Nakada, Natsuko Kondo, Satoshi Takeno, Yoshinori Sakurai

Article Radiobiology Review Year 2020

An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness

Post author By ISNCT
Post date June 29, 2022

Journal of Radiation Research, 2020

Tags Hiroki Tanaka, Journal of Radiation Research, Keizo Tano, Koji Ono, Minoru Suzuki, Shin Masunaga, Takushi Takata, Yoshinori Sakurai, Yu Sanada

Article Chemistry Small Boron compounds Year 2020

Experimental studies of boron neutron capture therapy (BNCT) using histone deacetylase inhibitor (HDACI) sodium butyrate, as a complementary drug for the treatment of poorly differentiated thyroid cancer (PDTC)

Post author By ISNCT
Post date June 29, 2022

Applied Radiation and Isotopes, 2020

Tags A. Rossini, Applied Radiation and Isotopes, C. Rodríguez, G. Juvenal, J. Longhino, M. Carpano, M. Dagrosa, M. Majdalani, M. Perona, M. Pisarev, R. Cabrini, S. Nievas

Article Clinical trials Phase II Studies Toxicity Year 2020

Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial

Post author By ISNCT
Post date May 20, 2022

Radiotherapy and Oncology, 2020